Velarion Records
Free. Unsubscribe any time.

NewAmsterdam Pharma Co N.V. (NAMS)

NewAmsterdam Pharma Co N.V. filed 15 Form 4 statements naming a Rule 10b5-1 trading plan in the 2025 filing year, by 5 reporting owners, covering 35 transactions and 1,325,341 shares. 15 carry the SEC's AFF10B5ONE flag; 0 name a plan only in a footnote. 8 results prints are on file in the same window.

What stands out

Trades in NewAmsterdam Pharma Co N.V. 35

Adoption dates in NewAmsterdam Pharma Co N.V. 0

Results prints in NewAmsterdam Pharma Co N.V. 8

Trades before a print in NewAmsterdam Pharma Co N.V. 0

Interval to NewAmsterdam Pharma Co N.V.’s next reported results date

How the interval and sources are counted →

Reported results dates on file

A proxy statement is on file for this company in the same window, which is where a company states its own trading policy.

Other companies with plan records

Sources: SEC EDGAR full-text search and the SEC submissions API.